Use of GLP-1 receptor agonists in the treatment of diabetes

TW202641502APending Publication Date: 2026-10-16JIANGSU HENGRUI MEDICINE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115100473
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-11
Filing Date
2026-01-06
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080875_001
    Figure TWG2TA001080875_001
  • Figure TWG2TA001080875_002
    Figure TWG2TA001080875_002
Patent Text Reader

Abstract

The disclosure relates to use of GLP-1 agonists in the treatment of diabetes. Specifically, the disclosure relates to Use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the treatment of diabetes.
Need to check novelty before this filing date? Find Prior Art